chr9-2191309-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003070.5(SMARCA2):​c.4638C>G​(p.Asp1546Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 1,613,644 control chromosomes in the GnomAD database, including 17,786 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2599 hom., cov: 33)
Exomes 𝑓: 0.13 ( 15187 hom. )

Consequence

SMARCA2
NM_003070.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.114

Publications

50 publications found
Variant links:
Genes affected
SMARCA2 (HGNC:11098): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, which contains a trinucleotide repeat (CAG) length polymorphism. [provided by RefSeq, Jan 2014]
SMARCA2 Gene-Disease associations (from GenCC):
  • intellectual disability-sparse hair-brachydactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035037398).
BP6
Variant 9-2191309-C-G is Benign according to our data. Variant chr9-2191309-C-G is described in ClinVar as Benign. ClinVar VariationId is 126349.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.267 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA2NM_003070.5 linkc.4638C>G p.Asp1546Glu missense_variant Exon 33 of 34 ENST00000349721.8 NP_003061.3 P51531-1Q8N9Q1Q56A76

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA2ENST00000349721.8 linkc.4638C>G p.Asp1546Glu missense_variant Exon 33 of 34 5 NM_003070.5 ENSP00000265773.5 P51531-1

Frequencies

GnomAD3 genomes
AF:
0.172
AC:
26197
AN:
152044
Hom.:
2595
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.272
Gnomad AMI
AF:
0.0296
Gnomad AMR
AF:
0.180
Gnomad ASJ
AF:
0.101
Gnomad EAS
AF:
0.212
Gnomad SAS
AF:
0.252
Gnomad FIN
AF:
0.136
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.113
Gnomad OTH
AF:
0.164
GnomAD2 exomes
AF:
0.169
AC:
42451
AN:
251364
AF XY:
0.167
show subpopulations
Gnomad AFR exome
AF:
0.283
Gnomad AMR exome
AF:
0.247
Gnomad ASJ exome
AF:
0.0954
Gnomad EAS exome
AF:
0.218
Gnomad FIN exome
AF:
0.133
Gnomad NFE exome
AF:
0.111
Gnomad OTH exome
AF:
0.155
GnomAD4 exome
AF:
0.134
AC:
196379
AN:
1461482
Hom.:
15187
Cov.:
32
AF XY:
0.137
AC XY:
99456
AN XY:
727048
show subpopulations
African (AFR)
AF:
0.277
AC:
9275
AN:
33464
American (AMR)
AF:
0.236
AC:
10547
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0955
AC:
2494
AN:
26126
East Asian (EAS)
AF:
0.191
AC:
7583
AN:
39694
South Asian (SAS)
AF:
0.254
AC:
21939
AN:
86226
European-Finnish (FIN)
AF:
0.133
AC:
7100
AN:
53410
Middle Eastern (MID)
AF:
0.176
AC:
1018
AN:
5768
European-Non Finnish (NFE)
AF:
0.115
AC:
127500
AN:
1111710
Other (OTH)
AF:
0.148
AC:
8923
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
8168
16336
24504
32672
40840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4916
9832
14748
19664
24580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.172
AC:
26209
AN:
152162
Hom.:
2599
Cov.:
33
AF XY:
0.176
AC XY:
13075
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.271
AC:
11254
AN:
41504
American (AMR)
AF:
0.180
AC:
2750
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
350
AN:
3472
East Asian (EAS)
AF:
0.211
AC:
1095
AN:
5180
South Asian (SAS)
AF:
0.253
AC:
1220
AN:
4816
European-Finnish (FIN)
AF:
0.136
AC:
1436
AN:
10580
Middle Eastern (MID)
AF:
0.153
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
0.113
AC:
7688
AN:
68006
Other (OTH)
AF:
0.163
AC:
344
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1096
2192
3289
4385
5481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.129
Hom.:
460
Bravo
AF:
0.181
TwinsUK
AF:
0.123
AC:
457
ALSPAC
AF:
0.119
AC:
459
ESP6500AA
AF:
0.269
AC:
1187
ESP6500EA
AF:
0.112
AC:
962
ExAC
AF:
0.168
AC:
20440
Asia WGS
AF:
0.242
AC:
839
AN:
3478
EpiCase
AF:
0.116
EpiControl
AF:
0.117

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19363039) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Inborn genetic diseases Benign:1
Mar 16, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nicolaides-Baraitser syndrome Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nicolaides-Baraitser syndrome;C5443984:Blepharophimosis-impaired intellectual development syndrome Benign:1
Dec 06, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
18
DANN
Benign
0.55
DEOGEN2
Benign
0.11
.;.;T;.;T;.;.;T;.;.;T;.;.;T;T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.21
.;T;.;T;T;T;.;.;T;T;T;T;T;T;T
MetaRNN
Benign
0.0029
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.6
.;.;N;.;N;.;.;.;.;.;.;.;.;.;.
PhyloP100
0.11
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
0.54
N;.;N;N;N;.;.;.;N;N;N;N;.;.;.
REVEL
Benign
0.095
Sift
Benign
1.0
T;.;T;T;T;.;.;.;T;T;T;T;.;.;.
Sift4G
Benign
0.61
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0
B;.;B;B;B;.;.;B;B;.;B;.;.;.;.
Vest4
0.099
MutPred
0.039
.;.;Gain of methylation at K1547 (P = 0.1355);.;Gain of methylation at K1547 (P = 0.1355);.;.;.;.;.;.;.;.;.;.;
MPC
0.13
ClinPred
0.0091
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.041
gMVP
0.034
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2296212; hg19: chr9-2191309; COSMIC: COSV56646286; COSMIC: COSV56646286; API